NY A02129 | 2015-2016 | General Assembly

Status

Spectrum: Moderate Partisan Bill (Democrat 8-1)
Status: Introduced on January 15 2015 - 25% progression, died in committee
Action: 2016-01-06 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Amended) [HTML]

Summary

Establishes the New York end of life options act; authorizes the prescription of aid-in-dying medication to individuals with terminal illnesses; terminal illness means incurable and irreversible illness that has been medically confirmed that will result in death within six months; form must be signed by the qualified individual and by two witnesses; no liability or sanctions where the health care provider participates in good faith.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishes the New York end of life options act; authorizes the prescription of aid-in-dying medication to individuals with terminal illnesses; terminal illness means incurable and irreversible illness that has been medically confirmed that will result in death within six months; form must be signed by the qualified individual and by two witnesses; no liability or sanctions where the health care provider participates in good faith.

Sponsors


History

DateChamberAction
2016-01-06Assemblyreferred to health
2015-09-11Assemblyprint number 2129a
2015-09-11Assemblyamend (t) and recommit to health
2015-01-15Assemblyreferred to health

Same As/Similar To

S03685 (Same As) 2016-01-06 - REFERRED TO HEALTH

New York State Sources


Bill Comments

feedback